Abstract
Previous studies suggest that the human gut microbiome is dysregulated in islet autoimmunity, preceding the clinical onset of type 1 diabetes (T1D). The microbiota of the gut plays an important role in the regulation of bile acid (BA) metabolism. However, not much is known about the regulation of BAs during progression to T1D. Here, we analyzed BAs in a longitudinal series of serum (n= 333) and stool (n= 304) samples, collected at 3, 6, 12, 18, 24 and 36 months of age, from children who developed a single islet autoantibody (P1Ab), multiple islet autoantibodies (P2Ab), and controls (CTRs) who remained autoantibody (AAb) negative during the follow-up. In addition, we analyzed the stool microbiome by shotgun metagenomics in a subgroup of these children (n=111). Factor analysis showed that age had the strongest impact on BA and microbiome profiles. We found that, at an early age, the systemic BA (including taurine and glycine conjugates) and microbial secondary BA pathways were altered in the P2Ab group as compared to the P1Ab or CTR groups. Our findings thus suggest that dysregulated BA metabolism in early life may contribute to the risk and pathogenesis of T1D.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by the Academy of Finland postdoctoral grant (No. 323171 to S.L.), the Novo Nordisk Foundation (Grant no. NNF20OC0063971 to T.H. and M.O.), the Academy of Finland Centre of Excellence in Molecular Systems Immunology and Physiology Research 2012-17, No. 250114 to M.K. and M.O.), and the Academy of Finland project grant (No. 333981 to M.O.). Further support was received from the Swedish Research Council (grant no. 2016-05176 to T.H and M.O), Formas (grant no. 2019-00869 to T.H and M.O) and the Medical Research Funds, Helsinki University Hospital (to M.K.).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was conducted according to the guidelines in the Declaration of Helsinki. The Ethics Committee of the Hospital District of Helsinki and Uusimaa approved the study protocol. All families provided written informed consent prior to sample collection.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Abbreviations
- AED
- average European diet
- AGORA
- assembly of gut organisms through reconstruction and analysis
- BAs
- bile acids
- BSH
- bile salt hydrolase
- CA
- cholic acid
- CDCA
- chenodeoxycholic acid
- FSP
- faecal secretion potential
- EMP
- estimated metabolic potential
- FXR
- farnesoid X receptor
- GCA
- glycocholic acid
- GCDCA
- glycochenodeoxycholic acid
- GDCA
- glycodeoxycholic acid
- GEMs
- genome-scale metabolic models
- GSMM
- genome-scale metabolic modeling
- HCA
- hyocholic acid
- MCA
- muricholic acids
- MS
- mass spectrometry
- sIECs
- small intestinal epithelial cells
- TCA
- taurocholic acid
- TDCA
- taurodeoxycholic acid
- TGR5
- Takeda G protein-coupled membrane receptor 5
- THCA
- taurohyocholic acid
- UDCA
- ursodeoxycholic acid
- DCA
- deoxycholic acid
- UPLC-QqQMS
- ultra-performance liquid chromatography-tandem mass-spectrometry
- VMH
- virtual metabolic human database
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.